FDA Inspection 1251380 — Janssen Biotech Inc.
The FDA completed an inspection of Janssen Biotech Inc. on September 24, 2024 in Horsham, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 24, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Horsham, PA (United States)
Additional Details
Sponsor, Contract Research Organization